DocStoX is a free AI-powered research platform for Indian equity markets, covering 6,800+ NSE & BSE stocks with prices, fundamentals, 326 financial ratios, shareholding, FII/DII flows, F&O, IPOs, a visual screener and AI stock scoring.

Yes. DocStoX has a free tier covering stock research, the screener, FII/DII data and educational guides, plus a free MCP API tier (50 tool calls/day) for AI assistants. A Pro plan adds higher limits and advanced features.

What data does DocStoX cover?

Every NSE & BSE listed stock (6,800+ instruments): EOD and intraday prices, income statement / balance sheet / cash flow, 326 ratios, quarterly shareholding, promoter pledge, mutual-fund holdings, FII/DII flows, F&O and option-chain data, analyst forecasts, IPOs, corporate actions and news.

Can AI assistants like ChatGPT or Claude use DocStoX data?

Yes. DocStoX runs a public Model Context Protocol (MCP) server at https://mcp.docstox.com/mcp with 39 tools, so Claude, ChatGPT, Cursor and other MCP clients can pull Indian market data directly. Setup and a free key are at https://docstox.com/mcp.

All news

Neutral impactResults

Epigral Limited — Board Meeting Intimation

NSE 1 hr ago·22 Jul 2026, 6:27 am

Epigral

Epigral Limited has announced that its board will meet on July 27, 2026, to review and approve the company's unaudited financial results for the quarter ending June 2026. This is a standard corporate procedure where the board reviews the company's performance before the results are officially disclosed to the public and stock exchanges.

For investors, this meeting is a key milestone as it signals that the company is preparing to release its quarterly performance data. While the results themselves are not yet public, the announcement confirms that the company is on track to report its financial status for the period. This information helps investors track the company's operational progress and financial health.

Investors should watch for the official release of the unaudited results following the board meeting. The data will provide insights into the company's revenue, profitability, and overall operational efficiency, which are essential factors for evaluating the stock's current performance and future prospects.